Download 13th annual miami cancer meeting (mcm)

_____________
PRST STD
US Postage
PAID
Miami, FL
Permit No. 1429
Meetings, Events and Conference Coordinators, Inc.
P.O. Box 430376
Miami, FL 33243-0376
13TH ANNUAL MIAMI
CANCER MEETING (MCM):
“New Horizons in Treating Patients with
Cancer: The Saga of Personalized Medicine”
January 29-31, 2016
Conrad Hilton Hotel
Miami, Florida
13TH ANNUAL MIAMI CANCER MEETING (MCM):
“New Horizons in Treating Patients with Cancer: The Saga of Personalized Medicine”
January 29-31, 2016
Conrad Hilton Hotel
Miami, Florida
Program Directors
Luis E. Raez, M.D, FACP, FCCP
Medical Director
Memorial Cancer Institute
Director of Clinical Oncology Research
Memorial Health Care System
Clinical Associate Professor of Medicine
Herbert Wertheim College of Medicine
Florida International University
Miami, Florida
Caio Max S. Rocha Lima, M.D.
Hematology and Oncology
Associate Cancer Center Director for
Translational Research
Gibbs Cancer Center & Research Institute
CMO Guardian Research Network
Spartanburg Healthcare System
Spartanburg, SC
Edgardo S. Santos Castillero, M.D., FACP
Medical Director of Cancer Research
Thoracic and Head and Neck Cancer Programs
Eugene & Christine Lynn Cancer Institute
Associate Professor of Clinical Biomedical
Science
Charles E. Schmidt College of Medicine
Florida Atlantic University
Boca Raton, FL
Educational Committee
Eileen Butler, RN, MSN, OCN, CPHON
Dina Dumercy, Pharm.D., BCOP
Jessica MacIntrye, ARNP, NP-C, OCN
Daniel Petrylak, M.D.
Bruno Pacheco Pereira, M.D.
Luis E. Raez, M.D., FACP, FCCP
Caio Max S. Rocha Lima, M.D.
Edgardo S. Santos, M.D., FACP
Sponsored by
The Medical Educator Consortium
Educational Committee • Distinguished Faculty
Educational Committee
Eileen Butler, R.N., MSN. OCN, CPHON
Dina Dumercy, Pharm.D., BCOP
Jessica MacIntrye, ARNP, NP-C
Bruno Pacheco Pereira, M.D.
Daniel Petrylak, M.D.
Luis E. Raez, M.D., FACP, FCCP
Caio Max S. Rocha Lima, M.D.
Edgardo S. Santos Castillero, M.D., FACP
Distinguished Faculty
Pasquale W. Benedetto, M.D.
Professor of Medicine
Director, Hematology/Oncology Fellowship
Program
University of Miami/Sylvester Comprehensive
Cancer Center
Miami, FL
Eileen A. Butler, R.N., MSN, OCN, CPHON
Oncology Nurse Educator
Sylvester Comprehensive Cancer Center
University of Miami Miller School of Medicine
Miami, FL
Anelisa Coutinho, M.D.
Division of Gastrointestinal Oncology
Clinica Assistencia Muldiciplinar em Oncologia (AMO)
Salvador, Bahia, Brazil
Dina Dumercy, Pharm.D., BCOP
Clinical Coordinator Oncology
Memorial Cancer Institute
Pharmacy Department
Memorial Healthcare System
Hollywood, FL
Sergio A. Giralt, M.D.
Chief, Adult Bone Marrow Transplant Service;
Melvin Berlin Family Chair in Multiple Myeloma
Memorial Sloan Kettering Cancer Center
New York, NY
Henry Gomez Moreno, M.D.
President, Peruvian Oncology Medical Society
Attending Physician and Chair, Breast Cancer
Group
National Cancer of Institute (INEN)
Lima, Peru
Brian Hunis, M.D.
Director of Head & Neck Cancer and Quality
Memorial Cancer Institute
Clinical Associate Professor of Medicine
Herbert Wertheim College of Medicine
Florida International University
Hollywood, FL
Rami Komrokji, M.D.
Clinical Director, Associate Member, Department
of Malignant Hematology
H Lee Moffitt Cancer Center & Research Institute
Tampa, Florida
Primo Lara Jr., M.D.
Professor of Medicine
University of California Davis
School of Medicine
Associate Director for Translational Research
University of California Davis
Comprehensive Cancer Center
Sacramento, CA
Caio Max S. Rocha Lima, M.D.
Hematology and Oncology
Associate Cancer Center Director for Translational
Research
Gibbs Cancer Center & Research Institute
CMO Guardian Research Network
Spartanburg Healthcare System
Spartanburg, SC
Jose Lutzky, M.D.
Co-Chief, Hematology & Oncology
Director, Mount Sinai Melanoma Program
Mount Sinai Medical Center
Miami, FL
Christian Rolfo Cervetto, M.D., Ph.D.
Head of Unit Phase I - Early Clinical Trials
Director of Clinical Trial Management Program
Oncology Department, University Hospital
Antwerp, Belgium
Jessica MacIntyre, ARNP, NP-C
Sylvester Comprehensive Cancer Center
University of Miami Miller School of Medicine
Miami, FL
Eriberto Marques Jr., M.D.
Medical Director of Santa Agueda Hospital
Department of Medical Oncology
Member of SBOC/SLACOM
Recife-PE, Brazil
Raj Narayanan, M.D.
Chief of Vascular and
Interventional Radiology
Associate Professor of Clinical Radiology
Department of Radiology
Sylvester Comprehensive Cancer Center
University of Miami Miller School of Medicine
Miami, FL
Bruno Pacheco Pereira, M.D.
Medical Director
Multihemo/Multionco Hospital
Santa Joana Pernambuco University-UPE
Recife, Brazil
Jyoti Patel, M.D.
Leader Thoracic Oncology Program
Associate Professor, Medicine
Hematology Oncology Division
Feinberg School of Medicine
Chicago, IL
Mark Pegram, M.D.
Professor of Medicine
Director of the Breast Cancer Program
Co-Director of Molecular Therapeutic Program
Stanford University
Palo Alto, CA
Daniel Petrylak, M.D.
Director, Genitourinary Oncology Research
Program
Co-Director, Signal Transduction Program
Yale Comprehensive Cancer Center
Yale School of Medicine
New Haven, CT
Luis E. Raez, M.D, FACP, FCCP
Medical Director
Memorial Cancer Institute
Director of Clinical Oncology Research
Memorial Health Care System
Clinical Associate Professor of Medicine
Herbert Wertheim College of Medicine
Florida International University
Miami, Florida
Hope Rugo, M.D.
Professor of Medicine
Director, Breast Oncology and Clinical Trials
Education
University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
San Francisco, CA
Edgardo S. Santos Castillero, M.D., FACP
Medical Director of Cancer Research
Lynn Cancer Institute
Thoracic and Head and Neck Cancer Programs
Associate Professor of Clinical Biomedical Sciences
Florida Atlantic University
Boca Raton, Florida
Eduardo Sotomayor, M.D.
Director, George Washington University
Cancer Center
Professor of Medicine
George Washington University School of Medicine
& Health Sciences
Washington, DC.
James T. Thigpen, M.D.
Professor-Clinical and Division Director of
Hematology
Oncology, Hematology
The University of Mississippi Medical Center
Jackson, MS
Vicente Valero, M.D.
Professor, and Deputy Chairman
Breast Medical Oncology Department
Clinical Director, The Morgan Welch Inflammatory
Breast Cancer Research Program and Clinic
Associate Director, Nellie B. Connally Breast Center
The University of Texas M.D. Anderson Cancer
Center
Houston, TX
Adrienne M. Vazquez, MSN, ACNP-BC, AOCNP
Memorial Sloan Kettering Cancer Center
New York, NY
Gordana Vlahovic, M.D., MHS
Associate Professor of Medicine/Oncology
The Preston Robert Tisch Brain Tumor
Center at Duke
Duke University Medical Center
Durham, NC
13th Annual Miami Cancer Meeting (MCM):
“New Horizons in Treating Patients with Cancer: The Saga of Personalized Medicine”
CONFERENCE DESCRIPTION
based on patient’s tumor molecular profile.
This is a 2-day course designed for medical oncologists,
hematologists, radiation oncologists, surgical oncologists,
physician assistants (PA), advanced registered nurse
practitioners (ARNP), oncology nurses, registered
pharmacists, pharmacy technicians, and radiation therapists.
General practitioners (internal medicine and family medicine)
will have the benefit of review standard of care and new
developments in cancer management. Residents in training
and fellows from these specialties are encouraged to attend.
5) Identify and treat possible complications which may surge
with the use of chemotherapy, targeted treatments, and
immunotherapy; the proper use of supportive care.
Topics in solid tumors and hematological malignancies will
be reviewed; that will include topics in breast cancer, lung
cancer, gastrointestinal (GI) malignancies, genitourinary
(GU) cancers, gynecologic malignancies, head and neck
cancers, melanoma, and hematological malignancies such
as multiple myeloma, CLL and non-Hodgkin’s lymphoma,
and myelodysplastic syndrome. There will also be a special
session devoted to the area of supportive care in oncology,
with emphasis on bone metastasis, malignant hypercalcemia,
and management of chemotherapy and immunotherapyrelated side effects.
The areas of focus for this conference will include the current
standards of care in the treatment of all aforementioned
malignancies and new developments in these areas of cancer
care. There will be much emphasis on molecular diagnosis
and individualization of cancer therapy based on molecular
profiles.
Presentations from latest national (AACR 2015, ASCO 2015
and ASH 2016) and international forums (ESMO 2015 and
WCLC 2015) meetings will be discussed and guidelines of
cancer care will be emphasized. The participants in the
meeting will have the opportunity not only to learn, review,
and understand the state-of-the-art management in cancer
care but also engage in personal interaction with our panel
of experts in these subjects during our question and answer
sessions.
CONFERENCE OBJECTIVES
Upon completion of this course attendees will be able to:
1) Understand the latest advances in chemotherapy and
immunotherapy options available for lung cancer, breast
cancer, GI malignancies, GU malignancies, melanoma, brain
tumors, head and neck cancer as well as hematological
malignancies including multiple myeloma, NHL, MDS, and CLL.
2) Evaluate the current standards of care in the treatment of
a variety of solid and hematologic malignancies.
3) Discuss risks and benefits when combined modality
of treatment is delivered to patients who have localized
malignant processes (i.e., NSCLC, head and neck, prostate
cancer, and others).
4) Apply targeted therapies such as tyrosine kinase inhibitors,
antiangiogeneic agents, and other in different tumor types
ACCREDITATION
The Medical Educator Consortium is accredited by the
Accreditation Council for Continuing Medical Education to
provide continuing medical education for physicians.
CREDIT HOURS (CME)
The Medical Educator Consortium, designates this live
activity for a maximum of 13 AMA PRA Category 1 Credit(s)TM.
Physicians should only claim credit commensurate with the
extent of their participation in the activity.
NURSING CEU
Continuing Education Credit for Nurses will be awarded by
the University of Miami Nursing Education Department. A
total of 13 CEU’s will be awarded for attendance to all two
days of the conference. Participants may attend separately
on Friday for 2.8 credit hours, Saturday for 7.2 credit hours,
and Sunday 3.0 credit hours. A certificate of completion will
be provided to each participant at the end of the conference.
Credit will be entered into CE Broker.
PHARMACY CEU
This activity is approved for a total of 13 contact hours of
Continuing Education Credit for Pharmacists and Pharmacy
Technicians awarded by the University of Miami Sylvester
Comprehensive Cancer Center. Participants must attend all
day lectures to receive credit for that day. Partial credits are
not available. Where credits are approved on a sessionby-session basis, participants must attend each session in
its entirety to receive complete credit for the session. A
certificate of completion will be provided to each participant
at the end of the conference. Credit will be entered into CE
Broker. UMHC/Sylvester is approved by the Florida Board of
Pharmacy as a provider of continuing pharmacy education.
FACULTY DISCLOSURE STATEMENT
The Medical Educator Consortium (MEC) adheres to the
ACCME Standards for Commercial Support. All persons that
will be in a position to control the content of the CME Activity
are required to disclose all relevant financial relationships.
Faculty disclosure forms outlining this information will
be made available to all participants prior to educational
activity. MEC has also implemented a mechanism to identify
and resolve all conflicts of interest prior to the education
activity being delivered to learners. The source of all support
from commercial interests will also be disclosed to learners
prior to the beginning of the educational activity.
13th Annual Miami Cancer Meeting (MCM):
“New Horizons in Treating Patients with Cancer:
The Saga of Personalized Medicine”
PROGRAM AGENDA
Friday, January 29th, 2016
:
5:00 pm – 7:30 pm
Registration Open & Visit Exhibits
5:30 pm – 5:40 pm
Welcome and Introduction
Luis E. Raez
5:40 pm – 7:50 pm
Supportive Care and Palliative Therapy Session
Moderator: Dina Dumercy
5:40 pm – 6:10 pm
Management of Chemotherapy Induced Side-Effects
(Anemia, Neutropenia and Nausea & Vomiting)
Jessica MacIntyre
6:10 pm – 6:40 pm
Treatment of Bone Metastasis and Hypercalcemia
Eriberto Marques, Jr.
6:40 pm – 7:10 pm
Targeted Therapy and Immunotherapy:
Adverse Reactions in Cancer Patients
Adrienne Vazquez
7:10 pm – 7:40 pm
Keynote Speaker: New Immunotherapy Agents in Oncology.
Christian Rolfo
7:40 pm – 7:50 pm
Round Table Discussion and Q & A Session
Speakers: Jessica MacIntyre,
Adrienne M. Vazquez,
Eriberto Marques Jr, and
Christian Rolfo Cervetto
7:50 pm – 9:00 pm
Symposia Dinner (non CME)
6:30 am – 8:00 am
Registration Opens & Visit Exhibits
8:00 am – 8:40 am
Breakfast Symposium (non CME)
8:40 am – 10:30 am
Brain Tumors, Head & Neck Cancer and
Melanoma Session
Moderator: Brian Hunis
Malignant Brain Tumors: From Chemotherapy to
Targeted Agents and Immunotherapy
Gordana Vlahovic
Saturday, January 30th, 2016
8:40 am – 9:10 am
09:10 am –
9:10 am – 09:40 am
9:40 am – 10:10 am
What is Next in SCCHN? Still Chemotherapy and Radiation?
Are We Making Progress in Personalized Medicine?
Edgardo S. Santos
How to Choose the Best Treatment for Metastatic
Melanoma Patients? Molecular Profiling and More
Jose Lutzky
10:10 am – 10:30 am
Round Table Discussion and Q & A session
10:30 am – 10:45 am
Coffee Break & Visit Exhibits
10:45 am – 12:00 pm
Genitourinary Malignancies Section
Moderator: Edgardo S. Santos
10:45 am – 11:15 am
Target Therapy for Renal Cell Carcinoma:
How Can We Customize Treatment for Each Patient?
Primo Lara, Jr.
Systemic Therapy for Metastatic Prostate Cancer: How has it
evolved from Hormonal Therapy to New Targeted Agents?
Daniel Petrylak
11:15 am – 11:45 am
Speakers: Gordona Vlahovic,
Edgardo S. Santos and Jose Lutzky
11:45 am – 12:00 pm
Round Table Discussion and Q & A session
Speakers: Primo Lara, Jr. and
Daniel Petrylak
12:00 pm – 1:00 pm
Lunch Symposia (non-CME)
1:00 pm – 1:20 pm
Coffee Break and Visit Exhibits
1:20 pm – 2:35 pm
Gynecologic Malignancies and Sarcomas Session
Moderator: Luis E Raez
1:20 pm – 1:50 pm
Gynecologic Malignancies
James Thigpen
1:50 pm – 2:20 pm
Chemotherapy and Targeted Therapy for Soft Tissue Sarcomas
Pasquale W. Benedetto
PROGRAM AGENDA Continued...
2:20 pm – 2:35 pm
Round Table Discussion and Q & A session
Speakers: Thigpen, Benedetto
2:35 pm – 3:15 pm
Moderator: Edgardo S. Santos
3:15 pm – 3:30 pm
Patient Advocacy Program. Sponsored by
Bonnie Addario Lung Cancer Foundation (BALCF)
Coffee Break & Visit Exhibits
3:15 pm – 5:00 pm
Gastrointestinal Tumors Session
Moderator: Caio Max Rocha Lima
3:15: pm – 3:45 pm
Novel Advances and New Combinations to Treat Biliary
and Pancreas Cancers: What’s new?
Caio Max Rocha Lima
Standard of Care in the Management of mCRC and
how to decide based on Genomic Profile the best
therapeutic option
Annelisa Couthino
4:15 pm – 4:45 pm
Interventional Oncology in Gastrointestinal Malignancies
Govindarajan Narayanan
4:45 pm – 5:00 pm
Round Table Discussion and Q & A Session
Speakers: Caio Max Rocha Lima,
Annelisa Couthino and
Govindarajan Narayanan.
5:00 pm
Meeting adjourns for the day.
3:45 pm – 4:15 pm
Sunday, January 31st, 2016
7:00 am – 8:00 am
Registration Opens & Visit Exhibits
8:00 am – 8:40 am
Breakfast Symposia (non CME)
8:40 am – 10:05 am
Hematology Malignancies Session
Moderator: Eduardo M. Sotomayor
8:40 am – 9:05 am
New Challenges in the Treatment of Multiple Myeloma
Sergio Giralt
9:05 am – 9:30 am
Targeted Therapy for Non-Hodgkin’s
Lymphomas and CLL
Eduardo M. Sotomayor
9:30 am – 9:55 am
High Risk Myelodysplasia and Leukemia
Rami Komrokji
9:55 am – 10:05 am
Round Table Discussion and Q & A session
Speakers: Sergio Giralt,
Eduardo M. Sotomayor and
Rami Komrokji
10:05 am – 10:20 am
Coffee Break & Visit Exhibits
10:20 am – 11:40 pm
Lung Cancer Session
Moderator: Luis E. Raez
10:20 am – 10:45 am
Chemotherapy and Targeted Therapy for Squamous
Cell Carcinoma (SQCC) of the Lung
Luis E. Raez
Actionable Mutations in Non-Small
Cell Lung Cancer (NSCLC)
Edgardo S. Santos
Check-Point Inhibitors: Modern Immunotherapy
for Lung cancer
Jioty Patel
10:45 am – 11:10 am
11:10 am – 11:35 am
11:35 pm – 11:45 pm
Round Table Discussion and Q & A session
11:45 am – 12:45 pm
Lunch Symposia (non CME)
12:45 pm – 1:00 pm
Coffee Break and Visit Exhibits
1:00 pm – 2:15 pm
Breast Cancer Section
Moderator: Henry Gomez
1:00pm – 1:25 pm
Blockades and Barricades in the HER Family
Hope Rugo
1:25 pm – 1:50 pm
Genomics and Predictive biomarkers in breast cancer:
What do we have today and what the future will
bring for us?
Mark Pegram
1:50 pm – 2:15 pm
Metastatic Chemotherapy and Hormone Therapy
for Breast Cancer
Vicente Valero
2:15 pm – 2:35 pm
Round Table Discussion and Q & A session
2:35pm
Closing Remarks
Speakers: Luis E. Raez, Edgardo S. Santos
and Jioty Patel
Speakers: Hope Rugo, Mark Pegram
and Vicente Valero
REGISTRATION
HOTEL INFORMATION
Fees: $225 - Physicians
$ 90 - Residents, Fellows,
Nurses & Allied
Health Professionals
$275 - Professionals from the
Pharmaceutical or
Laboratory Industry
The Conrad Hilton Hotel Miami
1395 Brickell Avenue
Miami, FL 33131
Telephone: 305-503-6585 or 1-800-CONRADS
Website: http://conradhotels1.hilton.com
Registration fee includes all day admission
to the Friday evening, Saturday, and Sunday
scientific presentations. Refunds must be
provided in writing prior to December 20th,
2015. After the December 20th deadline any
cancellation will include a $50 administrative
charge. Register online at www.meccinc.com
Discover the luxury of the Conrad Miami, the premier hotel in South Florida,
combining the ultimate hotel service and the latest technological advancements
with the fashion sensibilities of downtown Miami. Located in the innovatively
designed structure of concave glass and steel, in the heart of the city’s financial
district, the Conrad Miami hotel overlooks Biscayne Bay in Florida.The Conrad
Miami has quick and easy access to many attractions in downtown Miami,
including South Beach, Coconut Grove and Key Biscayne and is also just 15
minutes from the Miami International Airport.
Register online at www.meccinc.com
For more information contact:
CONFERENCE MANAGEMENT
MECC (Meetings Events &
Conference Coordinators, Inc.)
1550 S Dixie Highway, Suite 202, Coral
Gables, FL 33146
Telephone: 305/663-1628
Office Fax: 305/675-2718
Teri Valls, Executive Director
email: [email protected]
The hotel is offering special rates during this conference of $299 Deluxe City
View; $329 Deluxe Bay View plus tax, European plan (no meals). The cut off date
to make reservations is January 4th, 2016, after this date reservations are subject
to hotel availability.
Make your reservations by calling 305-503-6585 and identify you as attending
the “Miami Cancer Meeting” group code “MEC” or using the link
Or visit our website at
www.meccinc.com
http://resweb.passkey.com/go/13thannual
REGISTRATION FORM
13th Annual Miami Cancer Meeting (MCM):
“New Horizons in Treating Patients with Cancer: The Saga of Personalized Medicine”
January 29-31, 2016
Conrad Hilton Hotel, Miami, FL
Register online at www.meccinc.com or Mail to: MECC, Inc. 1550 S Dixie Hwy #202, Coral Gables, FL 33146 or FAX to 305/675-2718.
Name __________________________________________________________________________ Degree __________________________
Address ___________________________________________________________________________________________________________
City _________________________________________________ State ______________________ Zip _____________________________
Telephone (_____)_____________________________________________ Fax (_____)__________________________________________
Email address _____________________________________________________________________________________________________
License #______________________________________________________ State _______________________________________________
Specialty _________________________________________________________________________________________________________
Type of Practice:
o Private
o Academic
o Hospital
o Resident/Fellow
Registration fee:
$ 225 - Physicians
$ 90 - Residents, Fellows, Nurses and Allied Health Professionals
$ 275 - Professionals from the Pharmaceutical or Laboratory Industry
I authorize MECC to charge my credit card i/a/o $______ for registration of this course using the following credit card.
Name on Card ________________________________________________________________ Exp. Date ___________________________
Card number _________________________________________________________________ CVV ________________________________
Authorized signer __________________________________________________________________________________________________
If you require special assistance or have specific dietary requirements, please contact MECC, Inc.
no later than January 4th, 2016 via email at [email protected].